Should You Buy Rocket Lab Stock Ahead of the SpaceX IPO?

SpaceX’s IPO, scheduled for June and touted as potentially the largest ever, is intensifying investor focus on the space economy. Rocket Lab is highlighted as the second-most-used launch company in the U.S., with an end-to-end space business, a $2.2 billion backlog, and a new $190 million U.S. defense contract for 20 HASTE hypersonic test flights over four years. The article is broadly constructive on Rocket Lab’s positioning, but it is primarily commentary rather than a new company-specific catalyst.

Analysis

The market is likely to trade this as a broad space-economy rerating, but the cleaner second-order beneficiary is not the headline launch name — it is the government-and-defense-adjacent supply chain. As private launch gets cheaper and more frequent, procurement shifts from bespoke, one-off aerospace builds toward reusable subsystems, test capacity, and mission software, which tends to favor businesses with recurring content and shorter qualification cycles. That makes the durable profit pool look more like “picks and shovels” than rockets.

The real catalyst is not the IPO itself but the validation effect: a large, liquid public comp can compress the perceived risk premium across the category for several quarters. That matters because space valuations are unusually duration-sensitive; if investors start capitalizing backlog and platform potential rather than current revenue, multiple expansion can outrun fundamentals in the near term. The flip side is that any delay in heavy-lift rollout or a slip in defense contract execution would hit confidence hard, since the market is implicitly underwriting a step-function in addressable payload size and program cadence.

Contrarianly, the crowd may be underestimating how much of the incremental upside is already in the stock after a strong pre-IPO narrative build. A backlog headline is helpful, but backlog in this vertical is only valuable if it converts without launch failures, cost overruns, or customer concentration headaches. The better way to play this may be via relative value versus other high-beta industrial/defense names rather than outright chasing the momentum; the setup is positive, but it is also one adverse operational event away from a sharp de-rating.

Key Decisions for Investors

• Long RKLB on pullbacks over the next 2-6 weeks, but size modestly; use a trailing stop ~12-15% below entry because the stock is likely to trade on sentiment around SpaceX and Neutron milestones rather than near-term fundamentals.
• Pair trade: long RKLB / short a basket of lower-growth defense primes over 1-3 months to express the thesis that launch-plus-components exposure should re-rate faster than mature contractors if space sentiment stays hot.
• Buy 3-6 month calls on RKLB into any pre-IPO rally fatigue; the skew should improve if the market starts pricing an ecosystem uplift, but cap risk by financing with a higher strike call spread.
• Avoid chasing the headline via broad IPO sentiment trades in the immediate post-announcement window; wait for the first operational update or backlog-to-revenue commentary, which is the more important catalyst for a sustained move.
• If Neutron timing slips or a launch failure hits, fade the move aggressively: the name is high-beta and likely to de-rate 20%+ quickly on execution disappointment.